Biochemical Mechanisms of Hepatic Encephalopathy

1983 ◽  
Vol 64 (3) ◽  
pp. 247-252 ◽  
Author(s):  
I. R. Crossley ◽  
E. N. Wardle ◽  
Roger Williams

Although there are similarities between the encephalopathy of acute hepatic failure and that due to cirrhosis, it is clear that some of the biochemical abnormalities arise in different ways and the relative roles of the various factors contributing to the production of encephalopathy may differ. in addition, in fulminant hepatic failure, changes in the permeability of the blood—brain barrier may enhance the effects of biochemical abnormalities and this may also be important in the genesis of cerebral oedema, which commonly complicates this form of encephalopathy. When considering encephalopathy complicating cirrhosis, it is important to recognize that the latter can be precipitated by a variety of insults each of which may lead to encephalopathy. Most research has concentrated on the accumulation in the blood of ‘toxic’ substances normally metabolized by the liver. Although no single toxin has yet been identified which alone can be responsible for hepatic encephalopathy, excess ammonia, mercaptans, fatty acids and an abnormal plasma amino acid profile have been incriminated in its pathogenesis. Irrespective of the ‘toxin’, three main pathogenetic mechanisms have been proposed to account for its action: (a) disturbed brain energy metabolism, (b) deranged neurotransmitter balance, (c) direct effects on neuronal membranes. These mechanisms are not regarded as mutually exclusive but have their final common effect of interrupting normal neurotransmission.

2018 ◽  
Vol 33 (1) ◽  
pp. 96
Author(s):  
Joo-Yun Kim ◽  
Hyun-Su Ri ◽  
Ji-Uk Yoon ◽  
Eun-Ji Choi ◽  
Hye-Jin Kim ◽  
...  

2021 ◽  
Vol 59 (1) ◽  
pp. 557-564
Author(s):  
Long Cheng ◽  
Xiaoying Wang ◽  
Xueni Ma ◽  
Huimei Xu ◽  
Yifan Yang ◽  
...  

2015 ◽  
Vol 4 (3) ◽  
pp. 707-717 ◽  
Author(s):  
Sílvio Terra Stefanello ◽  
Edovando José Flores da Rosa ◽  
Fernando Dobrachinski ◽  
Guilherme Pires Amaral ◽  
Nélson Rodrigues de Carvalho ◽  
...  

Hepatic encephalopathy is a common complication of severe acute hepatic failure and has been associated with high short-term mortality rates.


2016 ◽  
Vol 0 (3.74) ◽  
pp. 112
Author(s):  
I.A. Kuchinskaya ◽  
M.V. Bondar ◽  
D.B. Areshnikov ◽  
S.S. Shapoval ◽  
R.D. Dobush

Critical Care ◽  
10.1186/cc560 ◽  
1999 ◽  
Vol 3 (Suppl 1) ◽  
pp. P187
Author(s):  
MC DaSilva ◽  
M Gupta ◽  
MJ Holman ◽  
HG Yang ◽  
RL Conter ◽  
...  

2004 ◽  
Vol 17 (3) ◽  
pp. 163-171 ◽  
Author(s):  
Nils R. Frühauf ◽  
Karl J. Oldhafer ◽  
Stephanie Westermann ◽  
Georgios C. Sotiropoulos ◽  
Gernot M. Kaiser

2000 ◽  
Vol 124 (12) ◽  
pp. 1800-1803 ◽  
Author(s):  
Marius J-M. Ilario ◽  
Jose E. Ruiz ◽  
Constantine A. Axiotis

Abstract Massive hepatic necrosis following exposure to phenytoin and trimethoprim-sulfamethoxazole is a rare occurrence and to the best of our knowledge has not been reported previously. Acute hepatic failure following administration of trimethoprim-sulfamethoxazole has rarely been seen, and only 4 cases have been well documented pathologically. We report a case of acute liver failure in a 60-year-old woman following ingestion of phenytoin and trimethoprim-sulfamethoxazole concomitantly over a 9-day period. Autopsy findings revealed acute fulminant hepatic failure. This case demonstrates the effects of chemical-chemical interactions in the potentiation of hepatotoxicity of single agents and specifically illustrates the need for discontinuing trimethoprim-sulfamethoxazole in the presence of early liver injury.


Sign in / Sign up

Export Citation Format

Share Document